On September 28 uniMIND Central Session will host Mauro Cavarra for an open discussion on our recently published paper reviewing the different models of psychedelic-assisted psychotherapy used in clinical trials. The session will start at 7pm (CEST) and anyone is welcome to join via the MIND Community Platform.
Do psychedelics work for chronic pain? We asked the patients themselves! In our recent article we present the results of a survey study addressed to chronic pain sufferers who are using psychedelics (both in full doses and in microdoses) to seek relief. Our results support the hypothesis that both dosing regimens hold promise for chronic… Continue reading Analgesic potential of psychedelics in chronic pain sufferers: a population survey
Dr. Kim Kuypers will be speaking at the Annual Scientific Meeting & Clinical Lab Expo 2022 in Chicago on Monday July 25. Her talk will focus on the effects of psychedelics in full hallucinogenic doses and microdoses on human cognitive performance, empathy and wellbeing: implications for therapeutic applications. The session will consist of three speakers… Continue reading Annual Scientific Meeting & Clinical Lab Expo 2022
In a recent review paper by professor Arjan Blokland, the effects of scopolamine and biperiden (and pirenzepine) are compared in animal studies and related to findings in humans. Scopolamine is used as a golden standard to induce memory impairments in animals and man. It has been used to validate new drugs for dementia-related disorders. However,… Continue reading Scopolamine vs biperiden as cognitive deficit models: from animal to human research
It is with great joy that we post some of the photos take on the May 2022 edition of the Neuropsychology and Psychopharmacology Research Day. The event was a great opportunity to showcase all the research lines that are being pursued by each team, to exchange ideas in an open and welcoming atmosphere, to meet… Continue reading Research day May 2022
